Literature DB >> 17579355

Managing patient dose in interventional cardiology.

Stephen Balter1, Jeffrey Moses.   

Abstract

This paper introduces a methodology for managing the radiation delivered to individual patients, incidental to their fluoroscopically guided interventional procedures. Because rare, but devastating skin injuries have occurred, radiation should be monitored and managed as well as drugs or radiographic contrast media. Dose metrics such as the total dose delivered to a reference point (reference point dose) should be used for this purpose. Fluoroscopy time is a poor independent predictor of skin dose in an individual patient. The concept of a "significant dose" is introduced. This is a predetermined action level of the selected dose metric. The numerical value is set based on classes of patient and procedural factors. Exceeding this value triggers processes for clinical justification of radiation usage and patient follow-up. Slightly exceeding the significant dose threshold during a procedure should be highly unlikely to cause skin injury. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17579355     DOI: 10.1002/ccd.21141

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Local skin and eye lens equivalent doses in interventional neuroradiology.

Authors:  Michael Sandborg; Sandro Rossitti; Håkan Pettersson
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

2.  Radiation-induced noncancer risks in interventional cardiology: optimisation of procedures and staff and patient dose reduction.

Authors:  Zhonghua Sun; Aini AbAziz; Ahmad Khairuddin Md Yusof
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

3.  Application of reference air kerma alert levels for pediatric fluoroscopic examinations.

Authors:  Elanchezhian Somasundaram; Samuel L Brady; Keith J Strauss
Journal:  J Appl Clin Med Phys       Date:  2022-08-04       Impact factor: 2.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.